ustekinumab biosimilars on Prescription Blue Select (S5584-001)
Wezlana, Selarsdi, Pyzchiva and others
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 1 per 28 days.
$1,871.97
Patient pays / month, after deductible
$2,333.22
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
USTEKINUMAB 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $7,487.86 for a month. Other covered strengths are listed below.
Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| USTEKINUMAB 45 mg/.5mL Injection, Solution | 5 | $1,871.97 | PA · 1 per 28 days |
| USTEKINUMAB 45 mg/.5mL Injection, Solution | 5 | $2,244.91 | PA · 1 per 28 days |
| USTEKINUMAB 90 mg/mL Injection, Solution | 5 | $3,743.94 | PA · 2 per 28 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)565-1770. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5584-001